Final Round of Late-Breaking Clinical Trial Results Announced at VIVA22

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

Related Keywords

Singapore ,United States ,China ,Germany ,Thailand ,Christopherj Kwolek ,Wynn Las Vegas ,Danielj Bertges ,Ehrinj Armstrong ,Maureenp Kohi ,Tjuny Tang ,Boston Scientific Corporation Deds ,Society Consensus ,Medtronic ,Vascular Quality Initiative ,Society For Vascular Surgery ,Zenith ,Late Breaking Clinical Trials ,Wynn Las ,Vascular Interventional Advances ,Fixated Endograft Has Similar Outcomes ,Year Results ,Primary Analysis ,Randomized Data ,Sirolimus Drug Eluting Balloons ,Complex Below The Knee Atherosclerotic Disease ,Patients With Chronic Limb Threatening Ischemia ,Month Results From ,Walking Impairment Questionnaire ,Mean Rutherford ,Increasing Diversity ,Peripheral Artery Disease ,Boston Scientific Corporation ,Femoropopliteal Disease With ,Novel Intra Arterial Stent Graft ,Month Results ,Registry Based Study ,Paclitaxel Drug Coated Balloon Angioplasty ,In Stent Restenosis ,Vascular Surgery ,Pact Admiral ,Transatlantic Inter Society Consensus ,